The Handbook integrates 24 chapters with thoughtful contributions from a number of renowned authors and experts in the field. Thanks to the Publisher, the authors are allowed to present their chapters on their webpage.<\/p>\n
The International Handbook on Regulating Nanotechnologies contains the following contributions. Where we can offer you the opportunity to sneak into a chapter for free, a link is provided. The opening and closing chapters of the Editors can be accessed via the Risk Science Blog of Andrew A. Maynard (Co-Editor).<\/p>\n
1. Introduction: the regulatory challenges for nanotechnologies (Graeme A. Hodge, Diana M. Bowman and Andrew D. Maynard)
\n 2. Philosophy of technoscience in the regime of vigilance (Alfred Nordmann)
\n3. Tracing and disputing the story of nanotechnology (Chris Toumey)
\n4. The age of regulatory governance and nanotechnologies (Roger Brownsword)<\/p>\n
5. Nanotechnology captured (John Miles)
\n6. The scientific basis for regulating nanotechnologies (David Williams)
\n7. The current risk assessment paradigm in relation to the regulation of nanotechnologies (Qasim Chaudhry, Hans Bouwmeester and Rolf F. Hertel)
\n8. Regulating risk: the bigger picture (Karinne Ludlow and Peter Binks)
\n9. Producing safety or managing risks? How regulatory paradigms affect insurability (Thomas K. Epprecht)<\/p>\n
10. The evolving nanotechnology environmental, health, and safety landscape: A business perspective (Oliver Tassinari, Jurron Bradley and Michael Holman) 19. The role of NGOs in governing nanotechnologies: challenging the \u2018benefits versus risks\u2019 framing of nanotech innovation (Georgia Miller and Gyorgy Scrinis) 26. Conclusions: triggers, gaps, risks and trust (Andrew D. Maynard, Diana M. Bowman and Graeme A. Hodge)<\/p>\n
\n11. Regulation of carbon nanotubes and other high aspect ratio nanoparticles: approaching this challenge from the perspective of asbestos (Robert J. Aitken, Sheona Peters, Alan D Jones and Vicki Stone)
\n12. Approaching the nanoregulation problem in chemicals legislation in the EU and US (Markus Widmer and Christoph Meili)<\/a>
\n13. A good foundation? Regulatory oversight of nanotechnologies using cosmetics as a case study (Geert van Calster and Diana M. Bowman)
\n14. Therapeutic products: regulating drugs and medical devices (Rog\u00e9rio S\u00e1 Gaspar)
\n15. Regulatory perspectives on nanotechnologies in foods and food contact materials (Anna Gergely, Qasim Chaudhry and Diana M. Bowman)
\n16. Regulation of nanoscale materials under media-specific environmental laws (Linda Breggin and John Pendergrass)
\n17. Military applications: special conditions for regulation (J\u00fcrgen Altmann)
\n18. Regulating nanotechnology through intellectual property rights (Gregory N. Mandel)<\/p>\nPART IV: The Future Regulatory Landscape<\/h4>\n
\n20. Voluntary measures in nanotechnology risk governance: the difficulty of holding the wolf by the ears (Christoph Meili and Markus Widmer)<\/a>
\n21. The role of risk management frameworks and certification bodies (Thorsten Weidl, Gerhard Klein and Rolf Z\u00f6llner)
\n22. Risk governance in the field of nanotechnologies: core challenges of an integrative approach (Ortwin Renn and Antje Grobe)
\n23. International coordination and cooperation: the next agenda in nanomaterials regulation (Robert Falkner, Linda Breggin, Nico Jaspers, John Pendergrass and Read Porter)
\n24. Transnational regulation of nanotechnology: reality or romanticism? (Kenneth W. Abbott, Douglas J. Sylvester and Gary E. Marchant)
\n25. From novel materials to next generation nanotechnology: a new approach to regulating the products of nanotechnology (J. Clarence Davies)<\/p>\nPART V: Conclusion<\/h4>\n